GLIOBLASTOMA MULTIFORME
Clinical trials for GLIOBLASTOMA MULTIFORME explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA MULTIFORME trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA MULTIFORME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radioactive therapy targets Hard-to-Treat cancers in early trial
Disease control TerminatedThis early-stage study tested a new radioactive drug called 177Lu-FF58 in 24 people with advanced pancreatic, stomach, or brain cancers that had spread or come back. The main goal was to check the drug's safety and find the right dose. The study was stopped early, so results are …
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 16, 2026 23:49 UTC
-
Brain cancer drug trial halted after just two patients
Disease control TerminatedThis study tested a new drug called VAL-083 in people with glioblastoma, an aggressive brain cancer, that had come back after standard treatments. The goal was to see if VAL-083 could help patients live longer. However, the trial was stopped early after only 2 people enrolled, so…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: PHASE3 • Sponsor: DelMar Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New imaging agent shows promise for detecting Hard-to-Treat cancers
Diagnosis TerminatedThis study tested a new imaging agent called 68Ga-FF58 in 14 adults with certain advanced solid tumors, including glioblastoma and pancreatic cancer. The goal was to see how well it shows up on PET/CT scans and to check its safety. The study was stopped early, so results are limi…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: EARLY_PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Diagnosis
Last updated May 11, 2026 20:49 UTC
-
Antifungal drug fails to show promise in brain cancer trial
Knowledge-focused TerminatedThis early-phase study aimed to see if ketoconazole, a drug used for fungal infections, could enter glioblastoma brain tumors in high enough amounts to stop cancer cells from dividing. Only one person took part before the study was stopped early. The main goal was to measure drug…
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: EARLY_PHASE1 • Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC
-
Antifungal drug tested against deadly brain cancer
Knowledge-focused TerminatedThis early-stage study tested whether posaconazole, a drug normally used for fungal infections, can get into glioblastoma brain tumors at levels high enough to stop cancer cells from dividing. Only 7 people took part before the study was stopped early. The goal was to see if the …
Matched conditions: GLIOBLASTOMA MULTIFORME
Phase: EARLY_PHASE1 • Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated May 13, 2026 16:04 UTC
-
Could a simple fluid test replace brain surgery for kids with tumors?
Knowledge-focused TerminatedThis study looked at whether a liquid biopsy—testing the fluid around the brain and spinal cord—can find tumor DNA in children and young adults with brain tumors. Researchers collected extra samples during routine care from up to 57 participants. The goal was to see if this safer…
Matched conditions: GLIOBLASTOMA MULTIFORME
Sponsor: Pediatric Brain Tumor Consortium • Aim: Knowledge-focused
Last updated May 06, 2026 16:01 UTC